Shin-Ichiro Fujii

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 13

Top Venues

Biomolecules

Cancer science

ImmunoHorizons

Communications biology

RIKEN IMS

This page only lists publications with an associated author ORCID identifier.

Affiliation History

RIKEN IMS Apr 01 2004

Japan

Team leader :: Lab. for Immunotherapy

Publications

Masahiro Okada, Satoru Yamasaki, Hiroshi Nakazato, Yuhya Hirahara, Takuya Ishibashi, Masami Kawamura, Kanako Shimizu, Shin-Ichiro Fujii
ARID1A-Deficient Tumors Acquire Immunogenic Neoantigens during the Development of Resistance to Targeted Therapy. Cancer research 84 (17) (2024)
Tomonori Iyoda, Kanako Shimizu, Masami Kawamura, Jun Shinga, Takashi Watanabe, Koya Fukunaga, Taisei Mushiroda, Hideo Saka, Chiyoe Kitagawa, Shin-Ichiro Shimamatsu, Mitsuhiro Takenoyama, Youko Suehiro, Takumi Imai, Ayumi Shintani, Suminobu Ito, Shin-Ichiro Fujii
Augmenting Granzyme B-Expressing NK Cells by Invariant NKT Ligand-Loaded APCs in Patients with Postoperative Early Stage Non-Small Cell Lung Cancer: Results of a Randomized Phase II Study. ImmunoHorizons 7 (1) (2023)
Tomonori Iyoda, Satoru Yamasaki, Shogo Ueda, Kanako Shimizu, Shin-Ichiro Fujii
Natural Killer T and Natural Killer Cell-Based Immunotherapy Strategies Targeting Cancer. Biomolecules 13 (2) (2023)
Tomonori Iyoda, Kanako Shimizu, Takaho A Endo, Takashi Watanabe, Ichiro Taniuchi, Honoka Aoshima, Mikiko Satoh, Hiroshi Nakazato, Satoru Yamasaki, Shin-Ichiro Fujii
Zeb2 regulates differentiation of long-lived effector of invariant natural killer T cells. Communications biology 6 (1) (2023)
Tomonori Iyoda, Satoru Yamasaki, Shogo Ueda, Kanako Shimizu, Shin-Ichiro Fujii
Natural Killer T and Natural Killer Cell-Based Immunotherapy Strategies Targeting Cancer. Biomolecules 13 (2) (2023)
Tomonori Iyoda, Kanako Shimizu, Masami Kawamura, Jun Shinga, Takashi Watanabe, Koya Fukunaga, Taisei Mushiroda, Hideo Saka, Chiyoe Kitagawa, Shin-Ichiro Shimamatsu, Mitsuhiro Takenoyama, Youko Suehiro, Takumi Imai, Ayumi Shintani, Suminobu Ito, Shin-Ichiro Fujii
Augmenting Granzyme B-Expressing NK Cells by Invariant NKT Ligand-Loaded APCs in Patients with Postoperative Early Stage Non-Small Cell Lung Cancer: Results of a Randomized Phase II Study. ImmunoHorizons 7 (1) (2023)
Kanako Shimizu, Shogo Ueda, Masami Kawamura, Honoka Aoshima, Mikiko Satoh, Jun Nakabayashi, Shin-Ichiro Fujii
Combination of cancer vaccine with CD122-biased IL-2/anti-IL-2 Ab complex shapes the stem-like effector NK and CD8 + T cells against tumor. Journal for immunotherapy of cancer 11 (7) (2023)
Tomonori Iyoda, Satoru Yamasaki, Shogo Ueda, Kanako Shimizu, Shin-Ichiro Fujii
Natural Killer T and Natural Killer Cell-Based Immunotherapy Strategies Targeting Cancer. Biomolecules 13 (2) (2023)
Tomonori Iyoda, Satoru Yamasaki, Shogo Ueda, Kanako Shimizu, Shin-Ichiro Fujii
Natural Killer T and Natural Killer Cell-Based Immunotherapy Strategies Targeting Cancer. Biomolecules 13 (2) (2023)
Shin-Ichiro Fujii, Satoru Yamasaki, Kenichi Hanada, Shogo Ueda, Masami Kawamura, Kanako Shimizu
Cancer immunotherapy using artificial adjuvant vector cells to deliver NY-ESO-1 antigen to dendritic cells in situ. Cancer science 113 (3) (2022)
Kanako Shimizu, Shogo Ueda, Masami Kawamura, Mikiko Satoh, Shin-Ichiro Fujii
A single immunization with cellular vaccine confers dual protection against SARS-CoV-2 and cancer. Cancer science 113 (8) (2022)
Kanako Shimizu, Tomonori Iyoda, An Sanpei, Hiroshi Nakazato, Masahiro Okada, Shogo Ueda, Miyuki Kato-Murayama, Kazutaka Murayama, Mikako Shirouzu, Naoko Harada, Michihiro Hidaka, Shin-Ichiro Fujii
Identification of TCR repertoires in functionally competent cytotoxic T cells cross-reactive to SARS-CoV-2. Communications biology 4 (1) (2021)
Tomonori Iyoda, Satoru Yamasaki, Masami Kawamura, Motoki Ueda, Kon Son, Yoshihiro Ito, Kanako Shimizu, Shin-Ichiro Fujii
Optimal therapeutic strategy using antigen-containing liposomes selectively delivered to antigen-presenting cells. Cancer science 110 (3) (2019)

Shin-Ichiro Fujii.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Shin-Ichiro Fujii